Infinity Pharma (INFI) Misses Q1 EPS by 19c

Infinity Pharma (NASDAQ: INFI) reported Q1 EPS of ($0.24), $0.19 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $6.67 million.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Reading (RDI) Tops Q2 EPS by 4c